Catalyst Wire Dossier Catalyst Wire Dossier

Pegfilgrastim TPI-120

pegfilgrastim · Kashiv BioSciences, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegfilgrastim TPI-120, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic, Immunogenicity, and Safety Evaluation of Pegfilgrastim TPI-120 in Healthy Adults [Phase 1]

See pricing